BitTorrent 저작권 침해 사건 수사의 쟁점

이의돈,권헌영 한국저작권위원회 2020 계간 저작권 Vol.33 No.4

출현한 지 20년 가까이 된 비트토렌트 프로그램은 그동안 저작물 파일을 무단으로 공유하는 수단으로 확실히 자리잡았다. 그동안 별다른 제재나 기술적 조치 등 의무를 부과하지 못한 탓에 이용자도 계속 증가하는 추세이다. 저작권자들의 꾸준한 고소로 지속적인 관련자 수사가 이루어지고 있지만 토렌트 이용은 줄어들지 않고 있다. 그 이유는 토렌트를 이용한 저작권 침해 사건에서 수사 대상이 되는 자들이 제대로 처벌받지 못하고 있기 때문이다. 저작권자와 이용자, 파일 공유 서비스 운영자 간 상생이 요구되는 상황에서 이들 간 균형을 허무는 행위에 엄격한 법적 처벌이 요구됨에도 작금의 현실은 ‘저작권 보호’에 다소 취약한 방향으로 수사와 재판이 진행되는 것으로 느껴진다. 비트토렌트 저작권 침해 사건에서의 수사 대상은 토렌트 프로그램을 개발하고 배포하는 서비스 운영자, 시드파일 헤비업로더인 토렌트 사이트 운영자, 저작물 원본 파일 무단 배포자 등 크게 셋으로 나뉜다. 본 연구에서는 각 수사 대상자별 관련 판례 등을 검토하여 어떠한 이유에서 이들이 처벌되지 않고 있는지 살펴보고 처벌의 필요성 등을 제시한다. The BitTorrent program, which has been in existence for nearly 20 years, has certainly become a means of unauthorized sharing of copyrighted files. The number of users continues to increase due to the failure to impose obligations such as special sanctions and technical measures. The constant complaints of copyright holders have led to continuous investigations into those involved, but the use of torrents has not decreased. The reason is that those who are subject to investigation in the case of copyright infringement using Torrent are not being punished properly. Despite the need for co-prosperity between copyright holders, users and file-sharing service operators, the current reality is that investigations and trials are conducted in a way that is somewhat vulnerable to “protecting copyrights.” The investigation targets in the BitTorrent copyright infringement case are largely divided into three categories: service operators who develop and distribute Torrent programs, Torrent site operators who are seed file heavy uploaders, and unauthorized distributors of original copyright files for works. In this study, the relevant cases of each person subject to investigation are reviewed to see why they are not being punished and to suggest the necessity of punishment.

(산부인과령역 심포지움) 침윤성 자궁경부암의 예후 (방사선 치료)

이의돈 中央醫學社 1983 中央醫學 Vol.44 No.4

일반연제 발표 : 논문 ; 부인과학 : 종양학 ; 임상 : 자궁경암 15, 092예 및 수술 561예에 대한 임상적 고찰 - 1963년부터 1983년까지의 임상적 분석 -

이의돈,이제호,이경희,박기복 대한산부인과학회 1984 대한산부인과학회 학술대회 Vol.54 No.-

지역 주민의 팔로워십과 농촌 체험 마을만들기 성과

이의돈,임재만 한국부동산분석학회 2019 不動産學硏究 Vol.25 No.4

This paper studies the importance of local residents’ followership in strengthening the community consciousness, which is the final goal of rural village development program. We empirically analyze the relationship among factors by using survey reponses from 14 rural villages located in Gapyeong-gun, Gyeonggi-do. This study finds that the active participation and team spirit, among other behavioral characteristics, significantly enhance the output of rural village development program. Moreover, it is found that the perceptive change of leaders plays the role of mediation between the behavioral characteristics of followers and performances of rural village development. The mediating role is more pronounced when the leaders actively embrace the followers’ opinion through communication and cooperation with the members, rather than through a unilateral decision-making process and execution by the leaders. Lastly, socio-environmental factors do not play a moderating role between the behavioral characteristics of followers and the performance of rural village development. This paper contributes to the literature in that the results of this analysis show the impact of followership on the rural village development and provide a foundation of further studies on the rural village development program in the future. 본 연구는 농촌체험마을에서 지역주민인 팔로워의 중요성을 인식하고, 구조방정식을 통해 팔로워십 특성과 마을만들기의 궁극적 목표인 공동체 의식 강화의 관계를 실증 분석하는 것이다. 경기도 가평균에서 마을만들기 사업을 추진한 11개 마을을 대상으로 직접 방문하여 실시한 설문조사에 따른 연구결과는 다음과 같다. 첫째, 팔로워의 행동특성 중 능동적 참여, 팀 정신은 마을만들기 성과를 높여준다. 둘째, 리더의 인식변화가 팔로워 행동 특성과 마을만들기 성과 사이에서 매개효과를 보인다. 이러한 결과는 리더의 일방적 결정과 추진이 아니라 구성원들과 유대관계를 갖고 소통과 협력으로 팔로워의 의견을 능동적으로 수렴할 때 성과가 더 커진다. 셋째, 사회환경적 요인은 팔로워 행동특성과 마을만들기 성과 사이에서 조절효과를 나타내지 못했다. 본 연구는 팔로워십이 농촌체험마을 만들기에 미치는 영향을 확인하고 향후 농촌체험마을 만들기의 기초자료로 활용하는 것에 연구의 의의가 있다.

침윤성 자궁경부암의 예후 (방사선치료)

이의돈 대한산부인과학회 1979 Obstetrics & Gynecology Science Vol.22 No.12

질에 발생한 투명세포선암 ( Clear Cell Adenocarcinoma ) 의 1 례

이의돈(ED Rhee),이제호(JH Lee),이경희(KH Lee),박기복(KB Park),장자준(JJ Jang),배광범(KB Bai) 대한산부인과학회 1986 Obstetrics & Gynecology Science Vol.29 No.2

질에 발생한 투명세포선암 Clear cell adenocarcinoma of the vagina is one of the rarest of the malignant process in the human body. We have experienced a case of clear cell adenocarcinoma of the vagina, and report with literatures.

악성 질 흑색종의 1예

이의돈(ED Rhee),이경희(KH Lee),신순철(SC Shin),이진용(JY Lee) 대한산부인과학회 1974 Obstetrics & Gynecology Science Vol.17 No.1

질에서 발생하는 원발성흑색종은 대단히 희유한 종역이며 여러 가지 치료방법에도 불구하고 예후가 나쁜 것으로 되어 있으나 가능하면 초기에 국소임파절을 포함하여 광범위한 전질부 및 근치자궁수술을 시향하면 비교적 좋은 결과를 얻기도 한다. Primary malignant melanoma of the vagina is estremely rare disease and the prognosis for melanoma of vagina remains poor in spite of several types of treatment. A report of our case and a review of the literature are here with presented.

융모성 종양에 대한 임상통계학적 관찰

이의돈(ED Rhee) 대한산부인과학회 1973 Obstetrics & Gynecology Science Vol.16 No.8

The present work deals with trophoblastic disease patients admitted at Seoul National University Hospital, Dept. of Obstetrics & Gynecology, from Jan. 1962 to Dec. 1971. The disease wise distribution of patients, 167 in total, is hydatidiform mole 87, destructive mole 18, and choriocarcinoma 58. When compared with the terminated pregnancies (normal deliveries, ectopic pregnancies, abortion, and trophoblastic disease) in the same period, the incidence of hydatidiform mole occupies a ratio of 0.73% (1:137.9), that of destructive mole 0.15%(1:667.5), and that of choriocarcinoma 0.48%(1:206.3). The peak incidence of hydatidiform mole is in the twenies(60.9%), that of destrucitve mole in the forties (44.4%), and that of choriocarcinoma in the thirties (43.1%). Among 131 patients of trophoblastic tumors with sufficient records, 73 persons(55.7%) belong to the lower class in socioeconomic sense. Though trophoblastic disese is more frequent for multiparas than primiparas, 17 case have been observed for the latters: hydatidifrom mole: 14cases(16.1%), destructive mole: 1 case(5.6%), choriocarcinoma: 2 cases (3.4%). 31% of choriocarcinoma patients as their previous pregnancy is hydaitidiform mole, 37.9% for hydatidiform mole, 38.9% for destructive mole, and 050.1% for choriocarcinoma as their pervious pregnancy is abortion. Main symptoms of each disease may be summed up in the following was: Hydatidiform mole: amenorrhea 100%, vaginal bleeding 87.4%, emetic symptoms 78.2%, anemia 76.8%, unexpected enlargement of uterine size 63.3%, fever and chill 49.3%, toxemic symptoms 27.6%. Destructive mole: vaginal bleeding 83.3%, anemia 76.5%, unwanted smaller uterine size 38.4%. Choriocarcinoma: anemia 80.8%, vaginal bleeding 77.6%, fever and chill 42.1%, bloody sputum and cough 45.6%, hemoptysis and hemiplegia 12.3%. Out of 36 patients managed only by mean of vaginal expulsion (I.V.P. induced or D & C), 11.1% showed malignant changed, while no malignant changes were found in the patients teated with hysterectomy and/or chemotheraphy. In the destructive mole patients, 3 cases of metastasis(16.7%) were observe. The treatment of destructive solely with hysterectomy showed 40% of complete remission wheras hysterectomy and chemotheraphy combined results is an 100% complete remission. In 45 cases (77.6%) of choriocarcinoma, metastasis was confirmed at the time of admission, site metatstasis being lung 87.2%, vagina 28.9%, brain 11.1%, ovary 8.9% and bladder 6.7%. When treated with chemotheraphy 20.8% of patients reached to complete remission. However, chemotheraphy separately performed attained nosingle case of complete remission. In cases metatstasis was not confirmed, the ratio of complete remission invariable, that is 50%, regardless whether hysterectomy is separately managed or combined with chemotheraphy. When hysterectomy performed, theca lutein cyst was found, 38.2% for destructive mole, and 50% for choriocarcinoma. The most frequent symptoms after freated with M.T.X. are or following: Stomatitis(19.1%), Nausea & Anorexia(17.6%), chill & fevb(7.4%), pharyngitis(7.4), vesicle(5.9%), gingivitis(5.9), Dysphagia(4.4) & skin truption (2.9%). W.B.C. count in blood: below 3,000(11.8%) & platelet count: below 100,000 (704%).

자궁경암의 자궁강내 Radium 및 Co60에 의한 치료성적 - 1963년부터 1979년까지의 임상적 분석 -

이의돈(ED Rhee),이제호(JH Lee),이경희(KH Lee),박기복(KB Park),고경환(KH Koh),서성희(SH Seo),유성열(SY Yoo),김진용(CY Kim) 대한산부인과학회 1986 Obstetrics & Gynecology Science Vol.29 No.6

자궁경암의 자궁강내 Radium 및 Co60에 의한 치료성적 - 1963년부터 1979년까지의 임상적 분석 - From 1963 through 1979, 368 patients with carcinoma of the uterine cervix were treated with Intracavitary Radium and Co60 at Cancer Research Hospital, Seoul, Korea. The purpose of this report was to analyze the clinical data and survival rate of these patients. The results were as follows: 1. The clinical stage of 368 patients treated with ICR and Co60 were as follows; Stage IB, 32 cases(8.7%), IIA, 135 cases(36.7%), IIB 169 cases(45.9%), Ⅲ, 25 cases(6.8%), Ⅳ, 3 cases(0.8%), and Postoperation recurrent, 4 cases(1.1%). 2. The most frequent distribution of age was 41~50. 3. The results of histopathologic subtype were distributed as follows: Squamous cell carcinoma was 96.7%, Adenocarcinoma was 2.7% and Adenosquamous carcinoma was 0.5%. 4. The 5-year survival rates by stage in confirmed patients by follow up were Stage IB, 88.0%, IIA, 75.2%, IIB, 69.3%, Ⅲ, 55.0%, Ⅳ, 0%, and Postoperation recurrent, 50.0%. 5. The 10-year survival rates by stage in confirmed patients by follow up were Stage IB, 75.0%, IIA, 69.0%, IIB, 50.0%, Ⅲ, 30.0%, and Ⅳ, 0%.

자궁경부암종에서 방사선치료의 반응성과 p53 , bcl - 2 및 bax 단백질 발현

이의돈(Eui Don Lee),이광범(Kwang Beom Lee),석원익(Won Ik Suk),최준렬(Jun Ryeoul Choi),이종민(Jong Min Lee),이지성,박찬용(Chan Yong Park),하승연(Seung Yeon Ha),이규찬(Kyu Chan Lee) 대한산부인과학회 2002 Obstetrics & Gynecology Science Vol.45 No.10

목적 : 자궁경부암종에서 방사선 치료의 예후 판정에 apoptosis 관련인자인 p53, bcl-2 및 bax 등이 유용한지를 알아보기 위해 본 연구를 시행함. 연구 방법 : 1998년 1월부터 2000년 5월까지 가천의대 길병원에 내원한 국소적으로 진행된 자궁경부암 (stage Ⅱb와 Ⅲ) 환자 30명을 대상으로 방사선치료를 받기 전에 자궁경부 조직 생검을 실시하여 Bcl-2, p53 및 bax에 대한 면역조직화학적 염색을 시행하였다. 결과 : 1. P53의 발현은 방사선 치료의 비관해군에서 관해군에 비하여 많이 관찰되었으나 통계적으로 유의한 차이는 없었다 (p=0.43). 2. Bcl-2의 발현은 방사선 치료의 비관해군에서 관해군에 비하여 유의하게 많이 관찰되었다 (p=0.001). 3. Bax의 발현은 방사선 치료의 관해군에서 비관해군에 비하여 유의하게 많이 관찰되었다 (p=0.04). 결론 : Bcl-2와 bax의 발현은 방사선치료의 반응성과 관련이 있으며 자궁경부암종에서 예후인자로서 사용될 수 있을 것으로 사료되며 p53은 보다 많은 연구가 필요하리라 생각된다. Objective : To evaluate the relationship between p53, bcl-2 and bax protein expressions and clinical response to radiation therapy in patients with cervical squamous cell carcinoma and possibility of using them as an useful marker for sensitivity of radiation therapy. Methods : This study included 30 patients with locally advanced cervical squamous cell carcinoma (stage Ⅱb and Ⅲ). The specimens were obtained from cervical squamous cell carcinoma before radiation therapy by colposcopic directed biopsy and processed for immunohistochemical staining against p53, bcl-2 and bax. Results : 1. P53 was more expressed in nonresponders than responders to radiation therapy, but it was not statistically significantly different (p=0.43). 2. Bcl-2 was significantly more expressed in nonresponders than responders to radiation therapy (p=0.001). 3. Bax was significantly more expressed in responders than nonresponders to radiation therapy (p=0.04). Conclusion : Expression of bcl-2 and bax are correlated with the clinical response to radiation therapy and would be considered as an useful marker for sensitivity of radiation therapy. However, it is necessary to further evaluate p53.